End-to-End Pharmacovigilance Solutions Across APAC
iPharmX provides end-to-end pharmacovigilance and drug safety services for clinical trials and marketed products, helping pharmaceutical and biotechnology companies protect patients and meet global and local safety-reporting requirements.
Our services include PV system setup and maintenance, ICSR case processing, literature screening, signal detection, risk management, aggregate reporting, safety data exchange agreements, training and audit or inspection support.
Based in Singapore, we coordinate pharmacovigilance services across Southeast Asia and the wider APAC region through experienced local and regional professionals.
Comprehensive drug safety solutions designed to protect patients and ensure regulatory compliance
Establishment of robust pharmacovigilance systems and ongoing maintenance to meet evolving regulatory requirements. We ensure your PV system remains compliant and audit-ready.
Local pharmacovigilance contact, LPPV/NCP and country-level safety coordination across APAC, aligned with applicable health authority requirements.
End-to-end management of adverse event case processing, including intake, assessment, and submission of Individual Case Safety Reports (ICSRs), PBRER/PSUR, and DSUR preparation.
Continuous monitoring of safety data to detect signals of potential adverse effects, and implementation of risk management strategies to mitigate identified risks.
Preparation, review, Submission and distribution of RMPs in compliance with regulatory requirements, including maintenance of distribution records to ensure traceability and audit readiness.
Regular screening of scientific and medical literature for relevant safety information, and analysis of any identified case reports or safety signals in literature sources.
Pharmacovigilance support for organized data collection programs such as Patient Support Programs (PSPs), Market Research Programs (MRPs), and Digital Assets (DAs).
Provision of pharmacovigilance training for your staff and development of Standard Operating Procedures (SOPs) tailored to your processes, promoting compliance and consistency.
Design and implementation of post-marketing safety surveillance activities and observational studies to monitor product safety in real-world settings.
Preparation and maintenance of the PSMF, a comprehensive document that records your PV system details, ensuring it remains up-to-date and audit-ready.
Drafting and review of SDEAs to formally outline safety data exchange responsibilities between partners or affiliates, in compliance with regulatory expectations.
Assistance with pharmacovigilance audits and health authority inspections, including pre-audit gap analyses and preparation of required documentation
Expert drug safety solutions with proven regulatory compliance track record
Deep knowledge of global and regional PV regulations including FDA, EMA, ICH guidelines, and Asia-Pacific specific requirements.
Efficient case processing and reporting to meet regulatory timelines, ensuring your organization remains compliant with all submission deadlines.
We follow a comprehensive quality management system that emphasizes inspection and audit readiness, along with strong documentation practices. Our structured approach ensures data integrity, ongoing audit preparedness, and consistent regulatory compliance.
Contact us to discuss how our pharmacovigilance services can support your patient safety goals and regulatory compliance requirements.